Dennis J. Slamon, MD, PhD, received the Szent-Györgyi Prize for Progress in Cancer Research for his groundbreaking work in breast cancer treatment and the development of targeted therapies for various types of cancer. As the director of clinical and translational research at UCLA Health Jonsson Comprehensive Cancer Center, Slamon identified the HER2 gene, leading to the development of trastuzumab and palbociclib. His research has revolutionized cancer treatment by emphasizing targeting molecular mechanisms rather than cancer histology. Slamon’s work has had a lasting impact on cancer research, with his discoveries inspiring new approaches to treating cancer effectively.
Source link
Oncologist receives Szent-Györgyi Prize for groundbreaking research discoveries
